Bruker (BRKR) total debt

Total debt · fiscal 2025
$2.04B

Bruker (BRKR) carried total debt of $2.04B at the end of fiscal 2025 (December 31, 2025). That is 9.0% lower than the $2.25B of fiscal 2024. Figures as of 18 Nov 2026, 11:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$2.04B
Change on fiscal 2024
−9.0%
Growth, 5 years
+19.3% a year
Highest on record
$2.25Bfiscal 2024
Lowest on record
$303.10Mfiscal 2011
Fiscal years on record
132010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 19.3% a year. Across the 13 fiscal years on record (2010–2025), the highest was $2.25B in fiscal 2024 and the lowest $303.10M in fiscal 2011.

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

History · 13 fiscal years

Total debt by fiscal year

Bruker total debt, year by year

Bruker (BRKR) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$2.04B 9.0% down0.8×
2024$2.25B 62.8% up1.2×
2023$1.38B 8.6% up1.0×
2022$1.27B 4.8% down1.1×
2021$1.33B 58.0% up1.2×
2020$844.50M 3.8% up0.9×
2019$813.30M 138.4% up0.9×
2018$341.10M—0.4×
2014$355.00M 0.0%0.5×
2013$355.00M 5.3% up0.4×
2012$337.20M 11.3% up0.5×
2011$303.10M 37.7% down0.5×
2010$486.50M—0.9×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Bruker and comparable companies
CompanyTotal debtFiscal year
Spyre Therapeutics SYRE$4.63M2022
Qiagen QGEN$1.81B2025
Insulet PODD$949.20M2025
Bruker BRKR$2.04B2025
Globus Medical GMED$118.66M2025
Madrigal Pharmaceuticals MDGL$347.63M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker total debt: questions and answers

How much debt does Bruker have?

Bruker (BRKR) carried total debt of $2.04B at the end of fiscal 2025 (December 31, 2025). That is 9.0% lower than the $2.25B of fiscal 2024.

What is the growth rate of Bruker's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 19.3% a year.

What are the highest and lowest total debt figures on record for Bruker?

Across the 13 fiscal years on record (2010–2025), the highest was $2.25B in fiscal 2024 and the lowest $303.10M in fiscal 2011.

How does Bruker's debt compare with its equity?

Total debt was 0.8× shareholders' equity at the end of fiscal 2025.

How is Bruker's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Bruker it is on record here for 13 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/BRKR/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.